Results for: XCUR

Shares of Exicure Inc (XCUR), a low-float micro-cap biotechnology company, surged in after-hours trading after the company announced it received a Nasdaq listing extension. This extension grants Exicure until November 14th to meet all listing requirements. The stock’s significant volatility is attributed to its low float and micro-cap status, making it susceptible to price fluctuations.

Exicure, Inc. (XCUR) stock surged on Monday after the company announced debt-for-equity exchange agreements with its largest shareholder and an individual investor. The agreements involve the conversion of outstanding promissory notes into company shares, injecting much-needed capital into Exicure.